Literature DB >> 633055

Experimental investigations into the etiology of cholangitis following operation for biliary atresia.

J Hirsig, O Kara, P P Rickham.   

Abstract

Experimental operations carried out on young minipigs appear to show that cholangitis does not occur after simple ligation of the bile duct, but develops nearly invariably is the lymphatic drainage from the liver is also interrupted. The so-called "ascending" cholangitis observed after hepato-porto-entero anastomosis is probably not ascending at all, but blood-borne. When a hepatic portoenterostomy is carried out for biliary atresia, trauma to the lymphatics in the porta hepatis should be avoided and an additional omento-hepato-portopexy should be done. Recent clinical experience appears to confirm this hypothesis.

Entities:  

Mesh:

Year:  1978        PMID: 633055     DOI: 10.1016/s0022-3468(78)80213-9

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  5 in total

Review 1.  Neonatal obstructive cholangiopathy.

Authors:  D K Bhasin; S Mehta
Journal:  Indian J Pediatr       Date:  1984 Jan-Feb       Impact factor: 1.967

2.  Postoperative ascending cholangitis following portoenterostomy for biliary atresia: measures for control.

Authors:  J R Lilly; D C Hitch
Journal:  World J Surg       Date:  1978-09       Impact factor: 3.352

3.  Bacteria ascend to liver from the bilioenteric conduit after choledochojejunostomy in the cholestatic rat.

Authors:  C S Hsieh; L-T Huang; C C Huang; J J Wu; J H Chuang
Journal:  Pediatr Surg Int       Date:  2003-10-15       Impact factor: 1.827

Review 4.  Biliary atresia: recent progress.

Authors:  Mikelle D Bassett; Karen F Murray
Journal:  J Clin Gastroenterol       Date:  2008-07       Impact factor: 3.062

5.  Extrahepatic biliary atresia: preoperative assessment and surgical results in 47 consecutive cases.

Authors:  H T Psacharopoulos; E R Howard; B Portmann; A P Mowat
Journal:  Arch Dis Child       Date:  1980-11       Impact factor: 3.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.